Macrophage inflammatory protein: its characteristics, biological properties and role in the regulation of haemopoiesis.
AffiliationCRC Department of Experimental Haematology, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, UK.
MetadataShow full item record
AbstractStudies on haemopoietic stem cells had led to the realisation that negative feedback inhibitors play an important role in regulating their proliferation. One such molecule was identified as MIP-1 alpha. One of a family of cytokines, originally recognised as inflammatory molecules, MIP-1 alpha is now potentially valuable as a means of manipulating and protecting haemopoietic (and possibly other) stem cells during chemotherapy. This short review briefly considers the structural classification of MIP-1 alpha and its molecular relatives and indicates some of the probable human/murine equivalent molecules outlining the evidence for the equivalence of MIP-1 alpha (murine) and LD78 (human). Sources of MIP-1 alpha/LD78 are identified as monocyte/macrophage and lymphocytic cells and their role in inflammatory responses is seen to be significant. All proliferation in haemopoietic tissue is now recognised as a major target for MIP-1 alpha action. In vitro it synergises with certain growth factors to promote progenitor cell colony formation, but effects are dependent on the maturational age of the cells promoted. With more primitive cells it is seen as inhibitory. This property is particularly valuable in vivo where MIP-1 alpha can protect stem cells against the effects of cytotoxic agents. Since it appears that leukaemic stem cell proliferation is not inhibited, MIP-1 alpha/LD78 present great potential for stem cell protection in the theatre of cytotoxic therapies.
CitationMacrophage inflammatory protein: its characteristics, biological properties and role in the regulation of haemopoiesis. 1993, 57 (3):197-206 Int. J. Hematol.
JournalInternational Journal of Hematology
- Identification and characterization of an inhibitor of haemopoietic stem cell proliferation.
- Authors: Graham GJ, Wright EG, Hewick R, Wolpe SD, Wilkie NM, Donaldson D, Lorimore S, Pragnell IB
- Issue date: 1990 Mar 29
- Macrophage inflammatory protein-1 alpha enhances growth factor-stimulated phosphatidylcholine metabolism and increases cAMP levels in the human growth factor-dependent cell line M07e, events associated with growth suppression.
- Authors: Mantel C, Aronica S, Luo Z, Marshall MS, Kim YJ, Cooper S, Hague N, Broxmeyer HE
- Issue date: 1995 Mar 1
- Myelosuppressive effects in vivo with very low dosages of monomeric recombinant murine macrophage inflammatory protein-1 alpha.
- Authors: Cooper S, Mantel C, Broxmeyer HE
- Issue date: 1994 Feb
- Use of 5-fluorouracil to analyze the effect of macrophage inflammatory protein-1 alpha on long-term reconstituting stem cells in vivo.
- Authors: Quesniaux VF, Graham GJ, Pragnell I, Donaldson D, Wolpe SD, Iscove NN, Fagg B
- Issue date: 1993 Mar 15
- Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP1 alpha in vivo.
- Authors: Dunlop DJ, Wright EG, Lorimore S, Graham GJ, Holyoake T, Kerr DJ, Wolpe SD, Pragnell IB
- Issue date: 1992 May 1